Authors:
COSTEROUSSE O
ALLEGRINI J
CLOZEL JP
MENARD J
ALHENCGELAS F
Citation: O. Costerousse et al., ANGIOTENSIN-I-CONVERTING-ENZYME INHIBITION BUT NOT ANGIOTENSIN-II SUPPRESSION ALTERS ANGIOTENSIN-I-CONVERTING-ENZYME GENE-EXPRESSION IN VESSELS AND EPITHELIA, The Journal of pharmacology and experimental therapeutics, 284(3), 1998, pp. 1180-1187
Authors:
SCOTT WJ
RESNICK E
HUMMLER H
CLOZEL JP
BURGIN H
Citation: Wj. Scott et al., CARDIOVASCULAR ALTERATIONS IN RAT FETUSES EXPOSED TO CALCIUM-CHANNEL BLOCKERS, Reproductive toxicology, 11(2-3), 1997, pp. 207-214
Authors:
MULDER P
HOGIE M
RICHARD V
HENRY JP
CLOZEL JP
THUILLEZ C
Citation: P. Mulder et al., LONG-TERM EFFECTS OF A HIGH-DOSE OF THE ENDOTHELIN ANTAGONIST BOSENTAN IN A RAT MODEL OF CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 8170-8170
Authors:
MULDER P
RICHARD V
COMPAGNON P
HENRY JP
LALLEMAND F
CLOZEL JP
KOEN R
MACE B
THUILLEZ C
Citation: P. Mulder et al., INCREASED SURVIVAL AFTER LONG-TERM TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL CALCIUM-ANTAGONIST, IN HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 416-421
Citation: Jp. Clozel et al., DISCOVERY AND MAIN PHARMACOLOGICAL PROPERTIES OF MIBEFRADIL (RO-40-5967), THE FIRST SELECTIVE T-TYPE CALCIUM-CHANNEL BLOCKER, Journal of hypertension, 15, 1997, pp. 17-25
Authors:
ROUX S
BREU V
GILLER T
NEIDHART W
RAMUZ H
COASSOLO P
CLOZEL JP
CLOZEL M
Citation: S. Roux et al., RO-61-1790, A NEW HYDROSOLUBLE ENDOTHELIN ANTAGONIST - GENERAL PHARMACOLOGY AND EFFECTS ON EXPERIMENTAL CEREBRAL VASOSPASM, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1110-1118
Authors:
WOLNY A
CLOZEL JP
REIN J
MORY P
VOGT P
TURINO M
KIOWSKI W
FISCHLI W
Citation: A. Wolny et al., FUNCTIONAL AND BIOCHEMICAL-ANALYSIS OF ANGIOTENSIN II-FORMING PATHWAYS IN THE HUMAN HEART, Circulation research, 80(2), 1997, pp. 219-227
Authors:
DONCKIER JE
MASSART PE
HODEIGE D
VANMECHELEN H
CLOZEL JP
LALOUX O
KETELSLEGERS JM
CHARLIER AA
HEYNDRICKX GR
Citation: Je. Donckier et al., ADDITIONAL HYPOTENSIVE EFFECT OF ENDOTHELIN-1 RECEPTOR ANTAGONISM IN HYPERTENSIVE DOGS UNDER ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, Circulation, 96(4), 1997, pp. 1250-1256
Citation: P. Hess et al., TELEMETRY MONITORING OF PULMONARY ARTERIAL-PRESSURE IN FREELY MOVING RATS, Journal of applied physiology, 81(2), 1996, pp. 1027-1032
Citation: R. Schmitt et al., PREVENTION OF NEOINTIMA FORMATION BY MIBEFRADIL AFTER VASCULAR INJURYIN RATS - COMPARISON WITH ACE-INHIBITION, Cardiovascular drugs and therapy, 10(2), 1996, pp. 101-105
Authors:
KARAM H
HEUDES D
GONZALEZ MF
LOFFLER BM
CLOZEL M
CLOZEL JP
Citation: H. Karam et al., RESPECTIVE ROLE OF HUMORAL-FACTORS AND BLOOD-PRESSURE IN AORTIC REMODELING OF DOCA HYPERTENSIVE RATS, American journal of hypertension, 9(10), 1996, pp. 991-998
Authors:
MULLER DN
FISCHLI W
CLOZEL JP
BOHLENDER J
HILGERS KF
MENARD J
GANTEN D
LUFT FC
Citation: Dn. Muller et al., LOCAL ANGIOTENSIN (ANG) FORMATION AND HEMODYNAMIC-EFFECTS IN RAT HEARTS HARBORING THE HUMAN ANGIOTENSINOGEN (AOGEN) GENE, Hypertension, 28(3), 1996, pp. 123-123
Authors:
KARAM H
HEUDES D
BRUNEVAL P
GONZALES MF
LOFFLER BM
CLOZEL M
CLOZEL JP
Citation: H. Karam et al., ENDOTHELIN ANTAGONISM IN END-ORGAN DAMAGE OF SPONTANEOUSLY HYPERTENSIVE RATS - COMPARISON WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ANDCALCIUM ANTAGONISM, Hypertension, 28(3), 1996, pp. 379-385
Authors:
VACHER E
RICHER C
FORNES P
CLOZEL JP
GIUDICELLI JF
Citation: E. Vacher et al., MIBEFRADIL, A SELECTIVE CALCIUM T-CHANNEL BLOCKER, IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS, Journal of cardiovascular pharmacology, 27(5), 1996, pp. 686-694
Citation: S. Roux et al., MECHANISM OF THE ANTIISCHEMIC EFFECT OF MIBEFRADIL, A SELECTIVE T-CALCIUM-CHANNEL BLOCKER IN DOGS - COMPARISON WITH AMLODIPINE, Journal of cardiovascular pharmacology, 27(1), 1996, pp. 132-139
Authors:
DAGASSAN PH
BREU V
CLOZEL M
KUNZLI A
VOGT P
TURINA M
KIOWSKI W
CLOZEL JP
Citation: Ph. Dagassan et al., UP-REGULATION OF ENDOTHELIN-B RECEPTORS IN ATHEROSCLEROTIC HUMAN CORONARY-ARTERIES, Journal of cardiovascular pharmacology, 27(1), 1996, pp. 147-153
Citation: P. Coassolo et al., PHARMACOKINETICS OF REMIKIREN, A POTENT ORALLY-ACTIVE INHIBITOR OF HUMAN RENIN, IN RAT, DOG AND PRIMATES, Xenobiotica, 26(3), 1996, pp. 333-345
Citation: H. Watanabe et al., NIMODIPINE DOES NOT INCREASE CEREBRAL BLOOD-FLOW DURING SUBARACHNOID HEMORRHAGE IN THE RAT, Pharmacology, 53(1), 1996, pp. 1-10
Authors:
KARAM H
HEUDES D
HESS P
GONZALES MF
LOFFLER BM
CLOZEL M
CLOZEL JP
Citation: H. Karam et al., RESPECTIVE ROLE OF HUMORAL-FACTORS AND BLOOD-PRESSURE IN CARDIAC REMODELING OF DOCA HYPERTENSIVE RATS, Cardiovascular Research, 31(2), 1996, pp. 287-295
Citation: R. Schmitt et al., MIBEFRADIL PREVENTS NEOINTIMA FORMATION AFTER VASCULAR INJURY IN RATS- POSSIBLE ROLE OF THE BLOCKADE OF THE T-TYPE VOLTAGE-OPERATED CALCIUM-CHANNEL, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1161-1165
Authors:
HAHN M
TKACHUK VA
BOCHKOV VN
CHEGLAKOV IB
CLOZEL JP
Citation: M. Hahn et al., BLOCKADE OF RECEPTOR-OPERATED CALCIUM CHANNELS BY MIBEFRADIL (RO-40-4967) - EFFECTS OPT INTRACELLULAR CALCIUM AND PLATELET-AGGREGATION, Cardiovascular drugs and therapy, 9(6), 1995, pp. 815-821